NuVasive announces first patients in Japan treated with the XLIF surgical technique


After receiving Shonin approval for several products to offer extreme lateral interbody fusion (XLIF) procedures in Japan, NuVasive has announced that the very first XLIF procedures were performed at two different hospitals in Japan.

Russell Powers, NuVasive executive vice president of International, said, “We are absolutely thrilled that NuVasive now offers our comprehensive portfolio of innovative, procedurally integrated solutions for spine surgery in Japan, including XLIF. The XLIF procedure changed spine surgery in the USA with a minimally invasive approach designed to achieve reproducible, superior patient outcomes. We are eager to introduce XLIF across Japan, and to drive the shift toward minimally invasive approaches in the world’s second largest spine market. Our initial reception in Japan has been fantastic, and I applaud all of the NuVasive teams who worked to establish our Absolutely Responsive direct operation in this exciting new market.”